Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
3,636
Total Claims
$287K
Drug Cost
443
Beneficiaries
$647
Cost/Patient
Risk Score Breakdown 45/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+2208%
Opioid rate vs peers
59.5% vs 2.6% avg
-39%
Cost per patient vs peers
$647 vs $1,068 avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
59.5%
Opioid Rate
2,164
Opioid Claims
$156K
Opioid Cost
12.1%
Long-Acting Rate
This provider's opioid prescribing rate of 59.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 3,410 claims · $153K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl/Naloxone Hcl | 136 | $40K |
| Oxycodone Myristate | 61 | $39K |
| Buprenorphine Hcl | 30 | $30K |
| Oxycodone Hcl/Acetaminophen | 532 | $22K |
| Hydrocodone/Acetaminophen | 521 | $19K |
| Oxycodone Hcl | 706 | $18K |
| Semaglutide | 16 | $18K |
| Oxymorphone Hcl | 18 | $10K |
| Buprenorphine Hcl/Naloxone Hcl | 11 | $7,778 |
| Naloxone Hcl | 73 | $6,422 |
| Lidocaine | 30 | $5,326 |
| Gabapentin | 232 | $4,156 |
| Pregabalin | 132 | $3,343 |
| Morphine Sulfate | 104 | $3,054 |
| Carisoprodol | 40 | $2,004 |
Prescribing Profile
Patient Profile
63
Avg Age
59%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About